Literature DB >> 33757637

Defining the human and health care costs of chronic venous insufficiency.

Young Kim1, C Y Maximilian Png1, Brandon J Sumpio1, Charles S DeCarlo1, Anahita Dua2.   

Abstract

Chronic venous insufficiency (CVI) affects more than 25 million adults in the United States alone, and more 6 million with advanced stages of venous disease. The high incidence of CVI and the increasing costs of care, place a heavy financial burden on the US health care system. Recent studies estimate the total cost of care at more than $3 billion per year. These staggering numbers highlight the importance of timely diagnosis, treatment, and prevention of CVI. In this article, we review the epidemiology and prevalence of CVI, and its financial impact on national health care budget. Racial disparities in CVI and the impact of socioeconomic status on access to care are also discussed. Finally, we discuss CVI-related screening programs and the importance of preventative measures in venous disease.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33757637     DOI: 10.1053/j.semvascsurg.2021.02.007

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  1 in total

Review 1.  New Perspectives on Micronised Purified Flavonoid Fraction in Chronic Venous Disease: From Microvalves to Clinical Effectiveness.

Authors:  Eliete Bouskela; Marzia Lugli; Andrew Nicolaides
Journal:  Adv Ther       Date:  2022-08-11       Impact factor: 4.070

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.